Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Latest News about NRX Pharmaceuticals Inc/
Recent news which mentions NRX Pharmaceuticals Inc/
Lab Notes: Imvax advances brain cancer treatment; Wistar identifies promising compound for HIV patients
March 31, 2023
Tickers
INNO
Tags
Baudax Bio Inc/
Insurance
Inno
From
Business Journals
Lab Notes: Fox Chase Cancer Center researcher gets $1M grant; NRx raises funds
March 10, 2023
Tickers
INNO
Tags
Sanjay S/ Subramanian
Incyte Corp/
Inno
From
Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
December 09, 2022
Tickers
INNO
Tags
Medical Devices
Baudax Bio Inc/
Biotech
From
Business Journals
Lab notes: Adaptimmune to reduce workforce; NRx completes $11M debt financing
November 11, 2022
Tickers
INNO
Tags
Insurance
Tim Crew
Biotech
From
Business Journals
NRx Pharmaceuticals on search for new CEO
March 09, 2022
Tags
Insurance
Biotech
Coronavirus
From
Business Journals
Lab Notes: NRx seeks patent for Covid-19 therapy; Baudax Bio raises $4.2M
January 07, 2022
Tickers
INNO
Tags
Madrigal Pharmaceuticals Inc/
Inno
NRX Pharmaceuticals Inc/
From
Business Journals
NRx Pharmaceuticals takes second shot a getting emergency use approval for Covid-19 treatment
January 05, 2022
Tags
NRX Pharmaceuticals Inc/
Health Care
Jonathan Javitt
From
Business Journals
Lab Notes: Penn Medicine's $14M NIH grant; NRx seeks designation for drug candidate
December 30, 2021
Tickers
INNO
Tags
Jonathan Javitt
Carl June
Hospitals
From
Business Journals
NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug
November 29, 2021
Tags
Jonathan Javitt
NRX Pharmaceuticals Inc/
Health Care
From
Business Journals
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.